Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC Jr, Bennett JM, Benz EJ Jr, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ Jr, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA.

Mayo Clin Proc. 2015 Aug;90(8):996-1000. doi: 10.1016/j.mayocp.2015.06.001. Epub 2015 Jul 23. No abstract available.

2.

US oncologists call for government regulation to curb drug price rises.

McCarthy M.

BMJ. 2015 Jul 24;351:h4063. doi: 10.1136/bmj.h4063. No abstract available.

PMID:
26208848
3.

Lowering the High Cost of Cancer Drugs--I.

Braillon A.

Mayo Clin Proc. 2016 Mar;91(3):397. doi: 10.1016/j.mayocp.2015.12.013. No abstract available.

PMID:
26944245
4.

In Reply--Lowering the High Cost of Cancer Drugs.

Kantarjian H, Tefferi A.

Mayo Clin Proc. 2016 Mar;91(3):401-3. doi: 10.1016/j.mayocp.2015.12.016. No abstract available.

PMID:
26944248
5.

Lowering the High Cost of Cancer Drugs--IV.

Martenson JA.

Mayo Clin Proc. 2016 Mar;91(3):400-1. doi: 10.1016/j.mayocp.2015.12.011. No abstract available.

PMID:
26944247
6.

Lowering the High Cost of Cancer Drugs--III.

Attaran A, Mackey T, Beall R.

Mayo Clin Proc. 2016 Mar;91(3):399-400. doi: 10.1016/j.mayocp.2015.12.012. No abstract available.

PMID:
26944246
7.

Overspending driven by oversized single dose vials of cancer drugs.

Bach PB, Conti RM, Muller RJ, Schnorr GC, Saltz LB.

BMJ. 2016 Feb 29;352:i788. doi: 10.1136/bmj.i788. No abstract available.

PMID:
26932932
8.

News feature: Costly US anticancer drugs pose problems for doctors and patients.

Charatan F.

BMJ. 2008 Jul 14;337:a778. doi: 10.1136/bmj.a778. No abstract available.

9.

Paying a high price for cancer drugs.

[No authors listed]

Lancet. 2015 Aug 1;386(9992):404. doi: 10.1016/S0140-6736(15)61431-3. No abstract available.

PMID:
26251376
10.

Cancer drugs in the United States: Justum Pretium--the just price.

Kantarjian HM, Fojo T, Mathisen M, Zwelling LA.

J Clin Oncol. 2013 Oct 1;31(28):3600-4. doi: 10.1200/JCO.2013.49.1845. Epub 2013 May 6. No abstract available. Erratum in: J Clin Oncol. 2015 Oct 20;33(30):3523.

11.

Oncology drug pricing structure is broken.

Hutchinson L.

Nat Rev Clin Oncol. 2015 Sep;12(9):499. doi: 10.1038/nrclinonc.2015.141. No abstract available.

PMID:
26309071
12.

Oncology drug costs-the imaginary crisis?

Turck R.

Ann Oncol. 2017 Feb 1;28(2):427-431. doi: 10.1093/annonc/mdw548. No abstract available.

PMID:
27771612
13.

Drugs for cancer and copayments.

Finlay I, Crisp N.

BMJ. 2008 Jun 30;337:a527. doi: 10.1136/bmj.a527. No abstract available.

14.

Drugs are scarce as mix of programs aims to ease access.

Brower V.

J Natl Cancer Inst. 2009 Oct 7;101(19):1304-6. doi: 10.1093/jnci/djp343. Epub 2009 Sep 15. No abstract available.

PMID:
19755680
15.

The just price of cancer drugs and the growing cost of cancer care: oncologists need to be part of the solution.

Pfister DG.

J Clin Oncol. 2013 Oct 1;31(28):3487-9. doi: 10.1200/JCO.2013.50.3466. Epub 2013 Sep 3. No abstract available.

PMID:
24002517
16.

When will the U.S. flinch at cancer drug prices?

Vanchieri C.

J Natl Cancer Inst. 2005 May 4;97(9):624-6. No abstract available.

PMID:
15870428
17.

Medicare cost containment strategy targets several oncology drugs.

Twombly R.

J Natl Cancer Inst. 2004 Sep 1;96(17):1268-70. No abstract available.

PMID:
15339960
18.

Monthly and Median Costs of Cancer Drugs at the Time of FDA Approval 1965-2016.

[No authors listed]

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx173. No abstract available.

PMID:
29117395
19.

Market spiral pricing of cancer drugs.

Light DW, Kantarjian H.

Cancer. 2013 Nov 15;119(22):3900-2. doi: 10.1002/cncr.28321. Epub 2013 Sep 3. No abstract available.

20.

The UK Cancer Drugs Fund Experiment and the US Cancer Drug Cost Problem: Bearing the Cost of Cancer Drugs Until It Is Unbearable.

Prasad V, Mailankody S.

Mayo Clin Proc. 2016 Jun;91(6):707-12. doi: 10.1016/j.mayocp.2016.04.028. No abstract available.

PMID:
27261866

Supplemental Content

Support Center